Episode
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
- Podcast
- Hematologic Oncology Update
- Published
- Feb 18, 2026
- Duration seconds
- 3478
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations. CME information and select publications here .